These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 20237383)
1. Stability of an extemporaneously prepared clopidogrel oral suspension. Skillman KL; Caruthers RL; Johnson CE Am J Health Syst Pharm; 2010 Apr; 67(7):559-61. PubMed ID: 20237383 [TBL] [Abstract][Full Text] [Related]
2. Stability of extemporaneously prepared oxandrolone oral suspensions. Johnson CE; Cober MP; Hawkins KA; Julian JD Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300 [TBL] [Abstract][Full Text] [Related]
3. Stability of extemporaneously prepared moxifloxacin oral suspensions. Hutchinson DJ; Johnson CE; Klein KC Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374 [TBL] [Abstract][Full Text] [Related]
4. Stability of extemporaneously prepared rifaximin oral suspensions. Cober MP; Johnson CE; Lee J; Currie K Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533 [TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneously prepared glycopyrrolate oral suspensions. Cober MP; Johnson CE; Sudekum D; Penprase K Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869 [TBL] [Abstract][Full Text] [Related]
6. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension. Cober MP; Johnson CE Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574 [TBL] [Abstract][Full Text] [Related]
7. Stability of an extemporaneously prepared thalidomide suspension. Kraft S; Johnson CE; Tyler RP Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553 [TBL] [Abstract][Full Text] [Related]
8. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions. Caruthers RL; Johnson CE Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502 [TBL] [Abstract][Full Text] [Related]
9. Stability of an extemporaneously prepared tadalafil suspension. Pettit RS; Johnson CE; Caruthers RL Am J Health Syst Pharm; 2012 Apr; 69(7):592-4. PubMed ID: 22441791 [TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared cinacalcet oral suspensions. Thomson K; Hutchinson DJ; Chablani L Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267 [TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared rufinamide oral suspensions. Hutchinson DJ; Liou Y; Best R; Zhao F Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505 [TBL] [Abstract][Full Text] [Related]
12. Stability of an extemporaneous alcohol-free melatonin suspension. Johnson CE; Cober MP; Thome T; Rouse E Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684 [TBL] [Abstract][Full Text] [Related]
13. Stability of dolasetron in two oral liquid vehicles. Johnson CE; Wagner DS; Bussard WE Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116 [TBL] [Abstract][Full Text] [Related]
14. Stability of norfloxacin in an extemporaneously prepared oral liquid. Johnson CE; Price J; Hession JM Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605 [TBL] [Abstract][Full Text] [Related]
15. Stability of zonisamide in extemporaneously compounded oral suspensions. Abobo CV; Wei B; Liang D Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126 [TBL] [Abstract][Full Text] [Related]
16. Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension. Atkins JR; Lull ME; Decker AS; Hutchinson DJ Int J Pharm Compd; 2018; 22(4):326-328. PubMed ID: 30021187 [TBL] [Abstract][Full Text] [Related]